Top

Published in:

01-04-2011 | Clinical Brief

Spectrum of Kawasaki Disease

Authors: Megha Consul, Smita Mishra, Arvind Taneja

Published in: Indian Journal of Pediatrics | Issue 4/2011

Abstract

The authors report 22 patients of Kawasaki disease, diagnosed and treated over a period of 3 years at a tertiary care centre in New Delhi. Ten cases fullfiled the criteria of a “classical” case while 12 cases were “incomplete” cases. Echocardiography was performed in all cases and coronary artery involvement was found in 8 (36%) cases. All cases received high dose Intravenous Immunoglobulins (IVIG) as standard therapy. In two cases, a repeat dose of IVIG was required for defervescence to occur. All cases recovered after therapy. Those with coronary artery involvement were planned for a 2 years follow up from the time of diagnosis.

Kawasaki T, Kosaki F. Febrile oculo-oro-cutaneo-acro-desquamatous ndrome with or without acute non-suppurative cervical lymphadenitis in infancy and childhood: clinical observations of 50 cases. Arerugi. 1967;16:178–222.PubMed

Kawasaki T, Kosaki F, Okawa S, et al. A new infantile acute febrile mucocutaneous lymph syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271–6.PubMed

Taneja A, Saxena U. Mucocutaneous lymph node syndrome. Indian Pediatr. 1977;14:927–31.PubMed

Cimaz R, Sundel R. Atypical and incomplete Kawasaki disease, best practice & research clinical rheumatology. Pediatr Rheumatol. 2009;23:689–97.

Rowley AH, Duffy CE, Shulman ST. Prevention of giant aneurysms in Kawasaki Disease by intravenous gammaglobulin therapy. J Pediatr. 1988;113:290–4.PubMedCrossRef

Khubchandani R. Kawasaki disease–call for a national registry for India. Indian Pediatr. 2010;47:200.PubMed

Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747–71.PubMedCrossRef

de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki Disease. J Pediatr. 1998;133:254–8.PubMedCrossRef

Kurotobi S, Nagai T, Kawakami N, Sano T. Coronary diameter in normal infants, children and patients with Kawasaki Disease. Pediatr Int. 2002;44:1–4.PubMedCrossRef

10.

Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki Disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics. 1995;96:1057–61.PubMed

Title: Spectrum of Kawasaki Disease
Authors: Megha Consul
Smita Mishra
Arvind Taneja
Publication date: 01-04-2011
Publisher: Springer-Verlag
Published in: Indian Journal of Pediatrics / Issue 4/2011
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI: https://doi.org/10.1007/s12098-010-0356-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Spectrum of Kawasaki Disease

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2011

Latent Tuberculosis in Children: Diagnosis and Management

Neonatal Sepsis in a Tertiary Care Hospital in South India: Bacteriological Profile and Antibiotic Sensitivity Pattern

Falciparum Malaria in Children—A Brief Report of 305 Patients from Rourkela, Eastern India

Aetiology and Antimicrobial Resistance of Neonatal Sepsis at a Tertiary Care Centre in Eastern India: A 3 Year Study

Combating Anemia: The Greatest Challenge to the Medical Fraternity

Neonatal Tetanus Elimination in India—Still a Long Way to Go